Back to News
Market Impact: 0.25

Congress heads home without doing anything about spiraling health costs

Elections & Domestic PoliticsRegulation & LegislationFiscal Policy & BudgetTax & TariffsHealthcare & Biotech

Congress adjourned for the holidays without extending Affordable Care Act premium tax credits that expire on Jan. 1, a move that could force steeper health-insurance premiums for more than 20 million Americans. House GOP leadership declined to take up a Democratic three-year extension and Senate leaders say the upper chamber is unlikely to act, creating immediate policy risk for health insurers, consumer budgets and potential political fallout ahead of next year’s midterm elections.

Analysis

Market structure: The immediate winner set are large, diversified payors and PBMs (UnitedHealth UNH, CVS) that monetize Medicare Advantage and employer business; losers are pure-play ACA/exchange platforms and small regional carriers (e.g., eHealth EHTH, Bright Health BHG) exposed to individual-market enrollment shocks. Expect pricing power to bifurcate: carriers with MA and commercial books can pass through higher costs, while exchange specialists face higher loss ratios and potential exit; estimate 20–50% premium increases for affected exchange plans on Jan 1 could trigger 10–30% enrollment declines over 30–90 days. Risk assessment: Tail risks include a rapid bipartisan restoration of subsidies (positive shock for small carriers) or state-level emergency measures increasing Medicaid enrollment (benefit to Medicaid-focused insurers); both are medium-probability within 60–180 days. Immediate (days) volatility around Jan 1, short-term (weeks–months) earnings pressure for Q1–Q2, and long-term (12–24 months) political risk ahead of midterms could reprice healthcare equities by ±15–30%. Hidden dependency: enrollment churn feeds risk pools — adverse selection can amplify losses nonlinearly; key catalyst is any January legislative vote or court ruling. Trade implications: Favor long positions in UNH (2–3% portfolio), CVS (1–2%) and buys of defensive PBM exposure over 6–12 months; short/put exposure on EHTH and BHG (1–1.5% combined) for 3–9 months. Use options to hedge: buy 3–6 month put spreads on small-cap exchange names to limit capital while capturing vol; add 1–2% long-duration Treasuries (TLT) as a hedge if equity drawdown >5% or political gridlock persists past Jan 15. Pair trade: long UNH / short EHTH (ratio 2:1) to isolate individual-market risk. Contrarian angles: Consensus assumes permanent subsidy loss; that is underdone — a January patch or legal reversal is a realistic 25–40% chance and would sharply re-rate small-cap exchange names. The market may overprice systemic insurer downside; large-cap MA players have sticky cash flows and could rally 10–20% on any bipartisan fix. Historical parallel: 2017 subsidy debacles produced short-lived volatility but durable outperformance in MA names; unintended consequence: hospitals may face higher uncompensated-care costs, pressuring regional hospital chains (HCA, CYH) and creating acquisition targets for well-capitalized payors.